Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Microbiol ; 36(12): 3698-702, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9817901

ABSTRACT

We tested the carbon substrate assimilation patterns of 40 Corynebacterium amycolatum strains, 19 C. minutissimum strains, 50 C. striatum strains, and 1 C. xerosis strain with the Biotype 100 system (bioMérieux, Marcy-l'Etoile, France). Twelve carbon substrates of 99 allowed discrimination among the species tested. Additionally, assimilation of 3 of these 12 carbon substrates (maltose, N-acetyl-D-glucosamine, and phenylacetate) was tested with the API 20 NE identification system (bioMérieux). Since concordant results were observed with the two systems for these three carbon substrates, either identification system can be used as a supplementary tool to achieve phenotypic differential identification of C. amycolatum, C. minutissimum, and C. striatum in the clinical microbiology laboratory.


Subject(s)
Carbon/metabolism , Corynebacterium/classification , Corynebacterium/metabolism , Phenotype
2.
Int J Cancer ; 52(5): 766-70, 1992 Nov 11.
Article in English | MEDLINE | ID: mdl-1330935

ABSTRACT

The effects of EGF and TGF-beta 1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF-beta 1 inhibited clonogenic capacity and attenuated the EGF-mediated stimulation of DNA synthesis in OVCCR1 cells. TGF-beta 1 inhibited OVCCR1 cell proliferation by blocking the cell cycle at the G1/S transition. TGF-beta 1 did not affect either clonal or monolayer growth of IGROV1 cells. Both cell lines express type-I and type-III TGF-beta receptors, suggesting that the unresponsiveness of IGROV1 cells to TGF-beta 1 occurs at a post-receptor level. TGF-beta 1 mRNA was detected in OVCCR1 cells and in 8 out of 11 of the ovarian tumor specimens examined.


Subject(s)
Cell Division/drug effects , Growth Inhibitors/pharmacology , Ovarian Neoplasms/pathology , Transforming Growth Factor beta/pharmacology , DNA/biosynthesis , Epidermal Growth Factor/pharmacology , Female , Gene Expression , Humans , Ovarian Neoplasms/metabolism , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Receptors, Cell Surface/metabolism , Receptors, Transforming Growth Factor beta , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...